44.201.94.236
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Retina
Aflibercept after failed intravitreal bevacizumab may be effective in radiation retinopathy
Analysis suggests Medicare reimbursement undervalues complex cataract surgery
Sight Sciences Launches the Ergo-Series of the OMNI Surgical System
Orbital inflammatory reactions more advanced in smokers with Graves’ hyperthyroidism
Study evaluates prevalence of optometrists at academic medical centers
-Advertisement-
Retina
-Advertisement-
-Advertisement-
-Advertisement-
OSD / Dry Eye

Tear production and patient-reported symptoms were improved in patients with self-reported autoimmune diseases with dry eye disease (DED) treated with OC-01 (varenicline solution) nasal spray, according to a post hoc subgroup analysis from...

-Advertisement-
-Advertisement-
-Advertisement-
Inherited Retinal Disease
-Advertisement-
-Advertisement-
-Advertisement-

Polls & Quizzes

Quiz: Current Standing of Private Equity in Ophthalmology
Mar 15, 2023

Podcast Series

The Ophthalmic Project: The Latest in Refractive Surgery
Apr 17, 2022

Quizzes

Quiz: Current Standing of Private Equity in Ophthalmology
Mar 15, 2023

Videos

The optometrist’s role in managing AMD: Part 1
Mar 14, 2023
Glaucoma

 Sight Sciences, Inc, an eyecare technology company focused on developing and commercializing innovative technology that provides solutions intended to transform care and improve patients’ lives, today announced the United States launch of the Ergo-Series...

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-